Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Sorafenib inhibits MAPK-mediated proliferation in a Barrett's esophageal adenocarcinoma cell line.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Sorafenib inhibits MAPK-mediated proliferation in a Barrett's esophageal adenocarcinoma cell line.
Sorafenib inhibits MAPK-mediated proliferation in a Barrett's esophageal adenocarcinoma cell line. Dis Esophagus. 2008; 21(6):514-21.
View in:
PubMed
subject areas
Adenocarcinoma
Analysis of Variance
Barrett Esophagus
Benzenesulfonates
Blotting, Western
Cell Line, Tumor
Cell Proliferation
Dose-Response Relationship, Drug
Esophageal Neoplasms
Humans
Mitogen-Activated Protein Kinases
Niacinamide
Phenylurea Compounds
Probability
Protein Kinase Inhibitors
Pyridines
Reference Values
authors with profiles
Bruce Bissonnette
Ezra Cohen